Health ❯Diabetes ❯Type 2 Diabetes

Medications

Ozempic GLP-1 Receptor Agonists Mounjaro GLP-1 Injections Semaglutide FDA Approval Weight Management

NHS Expands Mounjaro Rollout as Regulators Flag Safety Concerns

GPs are prescribing tirzepatide to high-risk patients after the MHRA issued fresh warnings over fetal risk, unregulated online sales, reported deaths

UK Government Proposes Pharmacy Access for Weight-Loss Jabs Amid Rising Demand

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

Weight-Loss Injections Linked to Increased Fertility and 'Ozempic Babies'

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism